Genome Pharmaceuticals (Pvt.) Ltd.

16/I, Phase IV , Industrial Estate Hattar Pakistan

MATERIALS SAFETY DATA SHEET

1. IDENTIFICATION OF THE SUBSTANCE AND OF THE COMPANY:

Genome Pharmaceuticals (Pvt.) Ltd.
16/I, Phase IV, Industrial Estate Hattar Pakistan
Fax # (+92-995) 352574
Phone # (+92-995) 352571-73

2. COMPOSITION / INFORMATION ON INGREDIENTS:

Each film coated tablet contains;
Otilonium Bromide…....40mg
(Innovator’s specs)

3. PHYSICAL PROPERTIES:
White to off- white round unscored biconvex film coated tablet

4. HAZARDS IDENTIFICATION:
No as such

4.3 Other hazards

None.

5. STABILITY:
Stable under normal condition

6. STORAGE:
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature -20 °C

7. FIRST AID MEASUREMENTS

General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
 Genome Pharmaceuticals (Pvt.) Ltd.
16/I, Phase IV , Industrial Estate Hattar Pakistan

Inhalation:
Not applicable as not volatile.
Skin Contact:
Rinse under clear water.
Eyes Contact:
Rinse under clear water.
Ingestion:
Not applicable
In any case seek medical advice
.
8. FIRE FIGHTING MEASURES
Extinguishing media:
No special protection is required, as it is not flammable.

9. ACCIDENTAL RELEASE MEASURES

Personal precautions:
Not applicable

10. ENVIRONMENTAL PRECAUTION:

Use of HVAC system for fresh air ventilation and waste air exhaust mechanism

11. EXPOSURE CONTROLS & PERSONAL PROTECTION:

Use personal protection e.g. Goggles; Gloves & nose masks are adequate.

13. TOXICOLOGICAL & HEALTH HAZARD INFORMATION:

Not applicable

14. DISPOSAL CONSIDERATION PRODUCT:

Dispose in accordance with all applicable regulations.

15. OTHER INFORMATION:

HANDLING:
 Genome Pharmaceuticals (Pvt.) Ltd.
16/I, Phase IV , Industrial Estate Hattar Pakistan

HANDLE WITH CARE

WASTE MATERIAL RELEASE MEASURES:

Swap up, place in a bag and hold for waste disposal. Ventilate area and wash spill site after
material pack up is completes.

16. FIRE / EXPLOSION HAZARD:

Not a hazard

17. PRODUCT GROUPS & PROPOSED LEGAL STATUS:

Antispasmodic